mastoparan

Mastoparan is a small, cationic peptide originally isolated from wasp venom. It is a 14-amino-acid sequence, commonly cited as INLKALAALAKKIL, and is highly hydrophobic and amphipathic. With a net positive charge of about +3, mastoparan readily interacts with lipid membranes and is capable of inserting into phospholipid bilayers.

In mechanism and action, mastoparan is known for its ability to stimulate exocytosis in mammalian mast cells and basophils, provoking histamine release and degranulation. It can activate heterotrimeric G proteins directly, bypassing conventional cell-surface receptors, and thereby modulate downstream signaling pathways such as phospholipase C and, in some contexts, adenylyl cyclase activity. In addition to signaling effects, the peptide disrupts membranes and can form transient pores, contributing to its cytolytic and antimicrobial properties.

Biologically, mastoparan exhibits antimicrobial and insecticidal activities, and it has been used as a research tool to study membrane interactions, G-protein signaling, and exocytosis. Its properties have inspired the design of synthetic analogs and related antimicrobial peptides, with aims to retain beneficial activity while reducing cytotoxicity to human cells.

Applications and limitations: mastoparan serves primarily as a research reagent and a lead compound in peptide design. Its strong membrane activity and ability to trigger degranulation limit therapeutic use in clinical settings, necessitating modifications to improve selectivity and safety.

See also: venom peptides, antimicrobial peptides, mast cell degranulation.